Research location
Setúbal
Portugal
Advertisement
Research activity in Setúbal
PortugalCureCurrent currently publishes aggregate city-level research activity for this location: 36 trials and 38 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Setúbal
36 linked trials · page 1 of 1Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 1 site observation
RECRUITING
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 InflammationNCT06959095 · 2025-06-20 · 1 site observation
RECRUITING
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceNCT06492616 · 2024-09-27 · 2 site observations
RECRUITING
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational StudyNCT05809986 · 2023-11-27 · 1 site observation
RECRUITING
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)NCT06635824 · 2024-11-25 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationNCT06200207 · 2024-04-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationNCT05636176 · 2023-05-08 · 2 site observations
TERMINATED
Real-world Dapagliflozin Treatment in Patients With Heart Failure in Portugal (EVOLUTION-HF)NCT05465213 · 2022-11-28 · 1 site observation
COMPLETED
PORTHOS - PORTuguese Heart Failure Observational StudyNCT05434923 · 2022-06-30 · 1 site observation
COMPLETED
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C MutationNCT04685135 · 2021-02-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)NCT04934800 · 2019-12-10 · 1 site observation
COMPLETED
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 DiabetesNCT03811561 · 2019-05-08 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 DiabetesNCT03689374 · 2018-10-01 · 1 site observation
COMPLETED
Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection FractionNCT02929329 · 2017-01-06 · 1 site observation
COMPLETED
Plegridy Observational ProgramNCT02230969 · 2014-11-12 · 1 site observation
COMPLETED
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection FractionNCT02226120 · 2014-10-16 · 1 site observation
COMPLETED
Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) PatientsNCT02064868 · 2014-01-31 · 1 site observation
TERMINATED
Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis ParticipantsNCT04832399 · 2013-11-12 · 1 site observation
COMPLETED
A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported OutcomesNCT01930708 · 2013-10-31 · 1 site observation
COMPLETED
A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical CareNCT02236637 · 2013-06-14 · 1 site observation
COMPLETED
Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum PratenseNCT01567306 · 2011-10-01 · 1 site observation
COMPLETED
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-betaNCT01252355 · 2011-01-01 · 1 site observation
TERMINATED
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing RegimenNCT01254279 · 2010-12-01 · 1 site observation
COMPLETED
Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple SclerosisNCT01201356 · 2010-09-13 · 1 site observation
COMPLETED
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation
TERMINATED
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung CancerNCT00805194 · 2008-12-03 · 1 site observation
COMPLETED
Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel ChemotherapyNCT00676650 · 2008-07-01 · 1 site observation
TERMINATED
A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical PracticeNCT00505388 · 2007-07-01 · 1 site observation
COMPLETED
Tysabri Observational ProgramNCT00493298 · 2007-06-29 · 1 site observation
COMPLETED
Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC PatientsNCT00418886 · 2007-01-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.NCT00448591 · 2006-09-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.NCT00451906 · 2006-08-01 · 1 site observation
COMPLETED
STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent AsthmaNCT00252824 · 2005-07-01 · 1 site observation
COMPLETED
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00949910 · 2004-11-01 · 1 site observation
COMPLETED
Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)NCT00163462 · 2004-10-01 · 1 site observation
COMPLETED
Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).NCT00239408 · 2002-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.